Anti-EVA1A antibodies are used in the immunodetection of the protein eva-1 homolog A, regulator of programmed cell death. In humans, the canonical protein has a reported length of 152 amino acid residues and a mass of 17.5 kDa. Its subcellular localization is in the ER and lysosomes. It is reported to be expressed in the lung, kidney, liver, pancreas, placenta, but not in the heart and skeletal muscle. A member of the EVA1 protein family, EVA1A is known to act as a regulator of programmed cell death, mediating both autophagy and apoptosis. Synonyms for this target antigen include family with sequence similarity 176, member A, protein FAM176A, transmembrane protein 166, and protein eva-1 homolog A. EVA1A gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. A number of EVA1A antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. In addition, Immunohistochemistry is also a common application.